Welcome back to Endpoints Weekly! They say March comes in like a lion and out like a lamb, but two pharma giants made a roar

Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies.

President Donald Trump has signed an executive order confirming that drug products that come from a subset of countries and manufacturers will face 100% tariffs

An ambitious Vancouver startup is trying to ensure the next big diabetes breakthrough retains its ties to Canada, unlike the insulin developers of a century

Pharma is gaining ground in a yearslong struggle over access to federal drug discounts. Drugmakers and the federal government have historically been on opposing sides